SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-078403
Filing Date
2008-12-24
Accepted
2008-12-24 13:02:31
Documents
7
Period of Report
2008-12-18
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-30940_18k.htm 8-K 35263
2 EX-10.1 a08-30940_1ex10d1.htm EX-10.1 296125
3 EX-10.2 a08-30940_1ex10d2.htm EX-10.2 777298
4 EX-10.3 a08-30940_1ex10d3.htm EX-10.3 518852
5 GRAPHIC g309401ki15i001.gif GRAPHIC 1933
6 GRAPHIC g309401ki15i002.jpg GRAPHIC 2062
7 GRAPHIC g309401kk07i001.gif GRAPHIC 18734
  Complete submission text file 0001104659-08-078403.txt   1660821
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 081269872
SIC: 2834 Pharmaceutical Preparations